Research Insights Archive

Home » Research & Resources » Research Insights »Research Insights Archive

May 1, 2017 – Adaptive deep brain stimulation for Parkinson

Journal of Neurology, Neurosurgery, and PsychiatryLittle S, Tripoliti E, Beudel M, Pogosyan A, Cagnan H, Herz D, Bestmann S, Aziz T, Cheeran B, Zrinzo L, Hariz M, Hyam J, Limousin P, Foltynie T, Brown P. Adaptive deep brain stimulation for Parkinson Journal of Neurology, Neurosurgery, and Psychiatry, 2016 Aug 16. pii: jnnp-2016-313518. doi: 10.1136/jnnp-2016-313518Click here to read the abstract.


April 1, 2017 – DBS means everything – for some time. Patients’ Perspectives on Daily Life with Deep Brain Stimulation for Parkinson’s Disease

Journal of Parkinson’s DiseaseHariz GM, Limousin P, Hamberg K.J DBS means everything – for some time. Patients’ Perspectives on Daily Life with Deep Brain Stimulation for Parkinson’s Disease Journal of Parkinson’s Disease, 2016 Mar 17;6(2):335-47. doi: 10.3233/JPD-160799Click here to read the abstract.


January 1, 2017 – Efficacies of globus pallidus stimulation and subthalamic nucleus stimulation for advanced Parkinson

Clinical interventions in agingTan ZG, Zhou Q, Huang T, Jiang Y. Clin Efficacies of globus pallidus stimulation and subthalamic nucleus stimulation for advanced Parkinson Clinical interventions in aging, 2016 Jun 21;11:777-86. doi: 10.2147/CIA.S105505. eCollection 2016.Parkinson’s disease (PD) is a common neurological condition that is initially treated with levodopa to control the motor symptoms.  The medications are frequently effective but as the disease progresses the medications are frequently not as effective and can cause adverse motor side effects (e.g. freezing and dyskinesias) for People with Parkinson’s disease (PWP).  Additional therapies were created, deep brain stimulation (DBS), in the 1990’s and have consistently shown efficacy in controlling motor symptoms for PWP.  Much of the earlier research focused on the motor control and did not pay as close attention to the nonmotor symptoms which can also be very disabling.  Recent research has focused on neurocognitive outcomes and these authors conducted a meta-analysis to review such studies.Click here to read the abstract.


Follow Us Follow us on TwitterFollow us on FacebookInstagram

Sign Up for Email Alerts

By providing your email you agree to receive periodic emails from The Parkinson Alliance.

Please tell us more about yourself:

This month is? (Anti-Spam)

Contact UsTerms Of UsePrivacy Policy

The Parkinson Alliance is a nonprofit, tax-exempt charitable organization under section 501(c)(3) of the Internal Revenue Code. Donations are tax-deductible as allowed by law. Copyright © 2018 The Parkinson Alliance. All rights reserved.